Real-world Comparative Effectiveness of Evolocumab Versus Ezetimibe in Reducing the Risk of Fatal and Nonfatal Myocardial Infarction (20240027)First published 26/03/2025 Last updated 30/04/2025 EU PAS number: EUPAS1000000522StudyOngoing